Your browser doesn't support javascript.
loading
Late relapse after stopping sorafenib in allogeneic hematopoietic stem cell transplant recipients.
Gerull, S; Tschan-Plessl, A; Mathew, R; Nair, G; Passweg, J R; Halter, J P.
Afiliação
  • Gerull S; Division of Hematology, University Hospital Basel, Basel, Switzerland. sabine.gerull@usb.ch.
  • Tschan-Plessl A; Division of Hematology, University Hospital Basel, Basel, Switzerland.
  • Mathew R; Division of Hematology, University Hospital Basel, Basel, Switzerland.
  • Nair G; Division of Hematology, University Hospital Zurich, Zurich, Switzerland.
  • Passweg JR; Division of Hematology, University Hospital Basel, Basel, Switzerland.
  • Halter JP; Division of Hematology, University Hospital Basel, Basel, Switzerland.
Bone Marrow Transplant ; 54(5): 769-771, 2019 05.
Article em En | MEDLINE | ID: mdl-30401969

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Sorafenibe Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Sorafenibe Idioma: En Ano de publicação: 2019 Tipo de documento: Article